Vlad Coric, Chief Executive Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 100,000 shares at $50.15 ($5.0M) on 2019-03-12, disclosed to the SEC on 2019-03-14.
Open-market sale of $5.0M BHVN by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.15 | 25,955 | $1.3M | 26.0% |
| 2 | $50.15 | 26,007 | $1.3M | 26.0% |
| 3 | $50.02 | 7,883 | $394K | 7.9% |
| 4 | $50.02 | 8,262 | $413K | 8.3% |
| 5 | $50.02 | 16,110 | $806K | 16.1% |
| 6 | $50.03 | 15,783 |
| $790K |
| 15.8% |
| Total | $50.09 avg | 100,000 | $5.0M | 100% |
| Filing → |
| BHVN | BUY | 2024-10-03 | $1000K | — | Filing → |
| BHVN | BUY | 2024-04-23 | $5.0M | — | Filing → |
| BHVN | BUY | 2023-10-10 | $10.0M | — | Filing → |